188 related articles for article (PubMed ID: 34611047)
1. Trimethylamine oxide: a potential target for heart failure therapy.
Lv S; Wang Y; Zhang W; Shang H
Heart; 2022 May; 108(12):917-922. PubMed ID: 34611047
[TBL] [Abstract][Full Text] [Related]
2. Association of gut-related metabolites with outcome in acute heart failure.
Israr MZ; Bernieh D; Salzano A; Cassambai S; Yazaki Y; Heaney LM; Jones DJL; Ng LL; Suzuki T
Am Heart J; 2021 Apr; 234():71-80. PubMed ID: 33454370
[TBL] [Abstract][Full Text] [Related]
3. Flavin monooxygenase 3, the host hepatic enzyme in the metaorganismal trimethylamine N-oxide-generating pathway, modulates platelet responsiveness and thrombosis risk.
Zhu W; Buffa JA; Wang Z; Warrier M; Schugar R; Shih DM; Gupta N; Gregory JC; Org E; Fu X; Li L; DiDonato JA; Lusis AJ; Brown JM; Hazen SL
J Thromb Haemost; 2018 Sep; 16(9):1857-1872. PubMed ID: 29981269
[TBL] [Abstract][Full Text] [Related]
4. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Cardiol Clin; 2022 May; 40(2):161-169. PubMed ID: 35465890
[TBL] [Abstract][Full Text] [Related]
5. Suppression of intestinal microbiota-dependent production of pro-atherogenic trimethylamine N-oxide by shifting L-carnitine microbial degradation.
Kuka J; Liepinsh E; Makrecka-Kuka M; Liepins J; Cirule H; Gustina D; Loza E; Zharkova-Malkova O; Grinberga S; Pugovics O; Dambrova M
Life Sci; 2014 Nov; 117(2):84-92. PubMed ID: 25301199
[TBL] [Abstract][Full Text] [Related]
6. Effects of dietary choline, betaine, and L-carnitine on the generation of trimethylamine-N-oxide in healthy mice.
Yu ZL; Zhang LY; Jiang XM; Xue CH; Chi N; Zhang TT; Wang YM
J Food Sci; 2020 Jul; 85(7):2207-2215. PubMed ID: 32572979
[TBL] [Abstract][Full Text] [Related]
7. Small molecule inhibition of gut microbial choline trimethylamine lyase activity alters host cholesterol and bile acid metabolism.
Pathak P; Helsley RN; Brown AL; Buffa JA; Choucair I; Nemet I; Gogonea CB; Gogonea V; Wang Z; Garcia-Garcia JC; Cai L; Temel R; Sangwan N; Hazen SL; Brown JM
Am J Physiol Heart Circ Physiol; 2020 Jun; 318(6):H1474-H1486. PubMed ID: 32330092
[TBL] [Abstract][Full Text] [Related]
8. The Gut Axis Involvement in Heart Failure: Focus on Trimethylamine N-oxide.
Salzano A; Cassambai S; Yazaki Y; Israr MZ; Bernieh D; Wong M; Suzuki T
Heart Fail Clin; 2020 Jan; 16(1):23-31. PubMed ID: 31735312
[TBL] [Abstract][Full Text] [Related]
9. The gut microbial metabolite trimethylamine N-oxide and cardiovascular diseases.
Zhen J; Zhou Z; He M; Han HX; Lv EH; Wen PB; Liu X; Wang YT; Cai XC; Tian JQ; Zhang MY; Xiao L; Kang XX
Front Endocrinol (Lausanne); 2023; 14():1085041. PubMed ID: 36824355
[TBL] [Abstract][Full Text] [Related]
10. Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development.
Simó C; García-Cañas V
Food Funct; 2020 Aug; 11(8):6745-6776. PubMed ID: 32686802
[TBL] [Abstract][Full Text] [Related]
11. Dietary phenolics and their microbial metabolites are poor inhibitors of trimethylamine oxidation to trimethylamine N-oxide by hepatic flavin monooxygenase 3.
Iglesias-Carres L; Chadwick-Corbin SA; Sweet MG; Neilson AP
J Nutr Biochem; 2023 Oct; 120():109428. PubMed ID: 37549832
[TBL] [Abstract][Full Text] [Related]
12. The Role of a Gut Microbial-Derived Metabolite, Trimethylamine N-Oxide (TMAO), in Neurological Disorders.
Praveenraj SS; Sonali S; Anand N; Tousif HA; Vichitra C; Kalyan M; Kanna PV; Chandana KA; Shasthara P; Mahalakshmi AM; Yang J; Pandi-Perumal SR; Sakharkar MK; Chidambaram SB
Mol Neurobiol; 2022 Nov; 59(11):6684-6700. PubMed ID: 35986843
[TBL] [Abstract][Full Text] [Related]
13. Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
Trøseid M; Ueland T; Hov JR; Svardal A; Gregersen I; Dahl CP; Aakhus S; Gude E; Bjørndal B; Halvorsen B; Karlsen TH; Aukrust P; Gullestad L; Berge RK; Yndestad A
J Intern Med; 2015 Jun; 277(6):717-26. PubMed ID: 25382824
[TBL] [Abstract][Full Text] [Related]
14.
Wang Q; Guo M; Liu Y; Xu M; Shi L; Li X; Zhao J; Zhang H; Wang G; Chen W
Nutrients; 2022 Mar; 14(6):. PubMed ID: 35334879
[TBL] [Abstract][Full Text] [Related]
15. TMA/TMAO in Hypertension: Novel Horizons and Potential Therapies.
Zhang WQ; Wang YJ; Zhang A; Ding YJ; Zhang XN; Jia QJ; Zhu YP; Li YY; Lv SC; Zhang JP
J Cardiovasc Transl Res; 2021 Dec; 14(6):1117-1124. PubMed ID: 33709384
[TBL] [Abstract][Full Text] [Related]
16. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far?
Coutinho-Wolino KS; de F Cardozo LFM; de Oliveira Leal V; Mafra D; Stockler-Pinto MB
Eur J Nutr; 2021 Oct; 60(7):3567-3584. PubMed ID: 33533968
[TBL] [Abstract][Full Text] [Related]
17. Metagenomic analysis of gut microbiota reveals its role in trimethylamine metabolism in heart failure.
Emoto T; Hayashi T; Tabata T; Yamashita T; Watanabe H; Takahashi T; Gotoh Y; Kami K; Yoshida N; Saito Y; Tanaka H; Matsumoto K; Hayashi T; Yamada T; Hirata KI
Int J Cardiol; 2021 Sep; 338():138-142. PubMed ID: 34102245
[TBL] [Abstract][Full Text] [Related]
18. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide.
Romano KA; Vivas EI; Amador-Noguez D; Rey FE
mBio; 2015 Mar; 6(2):e02481. PubMed ID: 25784704
[TBL] [Abstract][Full Text] [Related]
19. Trimethylamine N-Oxide, the Microbiome, and Heart and Kidney Disease.
Zeisel SH; Warrier M
Annu Rev Nutr; 2017 Aug; 37():157-181. PubMed ID: 28715991
[TBL] [Abstract][Full Text] [Related]
20. Nonlethal Inhibition of Gut Microbial Trimethylamine N-oxide Production Improves Cardiac Function and Remodeling in a Murine Model of Heart Failure.
Organ CL; Li Z; Sharp TE; Polhemus DJ; Gupta N; Goodchild TT; Tang WHW; Hazen SL; Lefer DJ
J Am Heart Assoc; 2020 May; 9(10):e016223. PubMed ID: 32390485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]